ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstracts tagged "tumor necrosis factor (TNF) and tyrosine kinase inhibition"

  • Abstract Number: 1391 • ACR/ARHP Annual Meeting 2013

    Transporters As Drug Gateway Into The Cell For Specific Targeting Of Tyrosine Kinase Signaling Pathway In Rheumatoid Arthritis

    Saliha Harrach1, Christian Schmidt-Lauber2, Bayram Edemir3, Eberhard Schlatter1, Thomas Pap4, Giuliano Ciarimboli1 and Jessica Bertrand2, 1Experimental Nephrology, Medical Clinic und Policlinic D, University Hospital Münster, Münster, Germany, 2Institute of Experimental Musculoskeletal Medicine (IEMM), University Hospital Münster, Münster, Germany, 3Experimental Nephrology, Medical Clinic und Policlinic D, University Hospital Münster, Muenster, Germany, 4Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: Tyrosine kinase inhibitors (TKI) are effective in treating malignant disorders and were suggested to also have an impact on non-malignant diseases such as rheumatoid…
Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology